Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Kane Biotech Inc V.KNE

Alternate Symbol(s):  KNBIF

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired... see more

TSXV:KNE - Post Discussion

Kane Biotech Inc > News required to move price upwards
View:
Post by francoisl13 on Sep 14, 2023 2:18pm

News required to move price upwards

Now that short term credit facility concerns are behind us, at least until end of November, KNE needs to present some good news to the market in order to gains some momentum. Here are the one I see as short term priorities (ie.: before end of October/November);
1. News about the first Coactiv+ order from Progenacare shortly followed by one about the first product delivery;
2. News about the start of the DispersinB phase 1 trial with DoD;
3. News on the DispersinB clinical trial for acne with the UofMiami.
All of the above needs to be announced as soon as possible in order to meet previously published expectations by the company.
P.S.I'm still puzzled by the fact that Progenacare (and Salud Pharma) are not posting their deal with Kane about the Coactiv+ product and don't even show the product on their respective website.
GLTA
Comment by KevinOleary on Oct 06, 2023 10:02pm
1 How about waiting until the plant is able to produce coactiv in January? The dispersin trial started. You're far from being on top of this investment, so I get it that you're puzzled. 
Comment by francoisl13 on Oct 09, 2023 12:01pm
Well, if the plant is not ready to produce Coactiv+ as we speak then it is a very poorly execute process. The plant should have been up and ready to produce as soon as the FDA approval was granted. KNE should have been reporting sales in Q3, they didn't so, now the market is waiting for them to report, at a minimum, orders in Q4. Shipment in Q1 2024 will be fine but they need to show that ...more  
Comment by RoyMax123 on Oct 10, 2023 1:15pm
Frank, You have some answers here... https://www.facebook.com/watch/?v=292568703569665 DispersineB Clinical trial not started but near Acne Trial they are still working with university of Miami and  will also have a trial in Israel  They are currently producing Coactiv+ in house to bridge until the plant is fully producing etc. A good video so far. and here a picture of their first ...more  
Comment by RoyMax123 on Oct 10, 2023 1:27pm
And what surprise me is they expect to clean up the balance sheet  and have some cash left with the sale of the animal health business, which is more than I expected
Comment by francoisl13 on Oct 10, 2023 4:21pm
Thanks RoyMax123 for sharing the info...I must have been blind not to see the video and the (very nice) photo of the Coactiv+ product. I was waiting for a press release regarding the production of the Coactiv+ product but we got the info from Facebook and LinkedIN well, it is where news and info are being shared these days so,I better start looking more regularly at those site. P.S. I really like ...more  
Comment by KevinOleary on Oct 10, 2023 6:31pm
1. "Well, if the plant is not ready to produce Coactiv+ as we speak then it is a very poorly execute process. " No, blindness is not the problem; you're just plain stupid. You try to dumb down the world to your level by thinking you know more about getting a deal and getting a supply from a contract manager than kne management. Maybe the plant operator wouldn't touch this risky ...more  
Comment by francoisl13 on Oct 10, 2023 10:06pm
You are my shining star kevinoleary! Thanks for your very useful post. You're the type of person we all need on a forum. Now, take your pills and go to bed. Good night.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities